ICU Medical Inc (ICUI) stock
ICUINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3032% above fair value
$177.30−0.96 (-0.54%)
Close on Nov 12, 2026Market cap $4.43BP/E 73.6Yield –
ICU Medical profit margin
Profit margin (net margin) is net income as a percentage of revenue.
ICU Medical's profit margin for the twelve months ending Sep 30, 2026 was 2.8%. For fiscal 2025 it was 0.0%, against -4.9% the year before. The highest annual figure on record is 16.6% in fiscal 2016.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0.0% | +5.0 |
| FY2024 | Dec 31, 2024 | -4.9% | −3.6 |
| FY2023 | Dec 31, 2023 | -1.3% | +1.9 |
| FY2022 | Dec 31, 2022 | -3.3% | −11.1 |
| FY2021 | Dec 31, 2021 | 7.8% | +1.0 |
| FY2020 | Dec 31, 2020 | 6.8% | −1.1 |
| FY2019 | Dec 31, 2019 | 8.0% | +5.9 |
| FY2018 | Dec 31, 2018 | 2.1% | −3.3 |
| FY2017 | Dec 31, 2017 | 5.3% | −11.3 |
| FY2016 | Dec 31, 2016 | 16.6% | +3.5 |
| FY2015 | Dec 31, 2015 | 13.2% | +4.7 |
| FY2014 | Dec 31, 2014 | 8.5% | −4.4 |
| FY2013 | Dec 31, 2013 | 12.9% | −0.1 |
| FY2012 | Dec 31, 2012 | 13.0% | −1.8 |
| FY2011 | Dec 31, 2011 | 14.8% | +4.2 |
| FY2010 | Dec 31, 2010 | 10.6% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 4.8% | +5.4 |
| Q2 FY2026 | Jun 30, 2026 | 3.5% | −3.0 |
| Q1 FY2026 | Mar 31, 2026 | 5.7% | +8.2 |
| Q4 FY2025 | Dec 31, 2025 | -2.9% | +0.9 |
| Q3 FY2025 | Sep 30, 2025 | -0.6% | +5.0 |
| Q2 FY2025 | Jun 30, 2025 | 6.4% | +10.0 |
| Q1 FY2025 | Mar 31, 2025 | -2.6% | +4.4 |
| Q4 FY2024 | Dec 31, 2024 | -3.8% | −0.9 |
| Q3 FY2024 | Sep 30, 2024 | -5.6% | −6.9 |
| Q2 FY2024 | Jun 30, 2024 | -3.6% | −1.8 |
| Q1 FY2024 | Mar 31, 2024 | -7.0% | −5.2 |
| Q4 FY2023 | Dec 31, 2023 | -2.9% | +0.4 |
| Q3 FY2023 | Sep 30, 2023 | 1.3% | +2.9 |
| Q2 FY2023 | Jun 30, 2023 | -1.8% | −0.5 |
| Q1 FY2023 | Mar 31, 2023 | -1.7% | +5.3 |
| Q4 FY2022 | Dec 31, 2022 | -3.3% | −9.1 |
| Q3 FY2022 | Sep 30, 2022 | -1.6% | −10.9 |
| Q2 FY2022 | Jun 30, 2022 | -1.3% | −10.2 |
| Q1 FY2022 | Mar 31, 2022 | -7.0% | −14.5 |
| Q4 FY2021 | Dec 31, 2021 | 5.9% | −2.3 |
| Q3 FY2021 | Sep 30, 2021 | 9.2% | +1.4 |
| Q2 FY2021 | Jun 30, 2021 | 8.8% | +2.6 |
| Q1 FY2021 | Mar 31, 2021 | 7.5% | +2.3 |
| Q4 FY2020 | Dec 31, 2020 | 8.2% | +1.6 |
| Q3 FY2020 | Sep 30, 2020 | 7.8% | −0.8 |
| Q2 FY2020 | Jun 30, 2020 | 6.2% | −1.1 |
| Q1 FY2020 | Mar 31, 2020 | 5.1% | −4.2 |
| Q4 FY2019 | Dec 31, 2019 | 6.5% | +8.7 |
| Q3 FY2019 | Sep 30, 2019 | 8.6% | +8.6 |
| Q2 FY2019 | Jun 30, 2019 | 7.3% | −1.3 |
| Q1 FY2019 | Mar 31, 2019 | 9.4% | +8.1 |
| Q4 FY2018 | Dec 31, 2018 | -2.2% | −15.6 |
| Q3 FY2018 | Sep 30, 2018 | 0.1% | +0.0 |
| Q2 FY2018 | Jun 30, 2018 | 8.6% | +19.8 |
| Q1 FY2018 | Mar 31, 2018 | 1.3% | −21.2 |
| Q4 FY2017 | Dec 31, 2017 | 13.4% | +3.5 |
| Q3 FY2017 | Sep 30, 2017 | 0.0% | – |
| Q2 FY2017 | Jun 30, 2017 | -11.2% | – |
| Q1 FY2017 | Mar 31, 2017 | 22.5% | – |
| Q4 FY2016 | Dec 31, 2016 | 9.9% | – |
See a number that looks wrong?